Update on radioligand therapy with <sup>177</sup>Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects

Added 65 days ago (19.08.2021)
Authors: Valentina Fuoco; Giovanni Argiroffi; Stefania Mazzaglia; Alice Lorenzoni; Valentina Guadalupi; Andrea Franza; Federica Scalorbi; Gianluca Aliberti; Carlo Chiesa; Giuseppe Procopio; Ettore Seregni; Marco Maccauro
Journal: Tumori
Read article